Eagle Pharmaceuticals, Inc.
✓ Verified ManufacturerAbout
Eagle Pharmaceuticals Inc operates as a specialty pharmaceutical company from its headquarters in Woodcliff Lake, New Jersey, focused on developing and commercializing innovative injectable medicines that address critical unmet medical needs. The company specializes in first-in-class new chemical entities for oncology and critical care applications, leveraging advanced pharmaceutical development capabilities to bring breakthrough treatments to market. Eagle Pharmaceuticals maintains a strategic focus on injectable pharmaceutical products, with flagship medicines including BARHEMSYS amisulpride injection for postoperative nausea and vomiting prevention, and BYFAVO remimazolam for injection used in procedural sedation. The company combines rigorous scientific research with commercial expertise to develop differentiated therapeutic solutions that deliver measurable value to patients, healthcare providers, and health systems. Operating under the mission of putting science to work to serve a greater cause, Eagle Pharmaceuticals demonstrates commitment to improving healthcare outcomes through innovative drug development and manufacturing excellence. The publicly traded company maintains robust pharmaceutical manufacturing standards while pursuing strategic partnerships and acquisitions to expand its specialized product portfolio. Through focused research and development initiatives in critical therapeutic areas, Eagle Pharmaceuticals continues advancing its pipeline of novel injectable medications designed to address complex medical challenges and enhance patient care across hospital and clinical settings.